.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Details for Patent: 5,707,796

« Back to Dashboard

Details for Patent: 5,707,796

Title: Method for selecting nucleic acids on the basis of structure
Abstract:A method of selecting nucleic acids on the basis of physical structure is disclosed. A modification of the Systematic Evolution of Ligands by Exponential enrichment (SELEX) is used in conjunction with methods for differentiating between nucleic acid molecules on the basis of physical structure, such as chromatography, gel electrophoresis, solubility, and solvent partitioning. The disclosed method may be used in selecting single stranded DNA or RNA, or double stranded DNA or RNA. An example of the method selected nucleic acids of bent DNA. This method represents a new and powerful approach to select nucleic acid molecules with the physical structure required for specific biological activity, for example, in the regulation of gene expression.
Inventor(s): Gold; Larry (Boulder, CO), Beutel; Bruce (Suffern, NY)
Assignee: NeXstar Pharmaceuticals, Inc. (Boulder, CO)
Filing Date:Feb 22, 1994
Application Number:08/198,670
Claims:1. A method for identifying nucleic acid molecules from a candidate mixture of nucleic acids on the basis of a specific structural characteristic, comprising:

a) subjecting said candidate mixture of nucleic acids to partitioning;

b) selecting nucleic acids having said specific structural characteristic as determined by their partitioning behavior;

c) amplifying the selected nucleic acids to yield an amplification mixture enriched for nucleic acids having the specific structural characteristic;

d) repeating steps b) and c), whereby nucleic acid molecules having said specific structural characteristic may be identified.

2. The method of claim 1 wherein said partitioning is by gel electrophoresis.

3. The method of claim 2 wherein said structural characteristic is bent DNA.

4. The method of claim 1 wherein said structural characteristic is compact conformation.

5. The method of claim 1 wherein said partitioning is by exposure to a solvent.

6. The method of claim 1 wherein said partitioning is between two solvent phases.

7. The method of claim 1 wherein said nucleic acid is single or double stranded DNA.

8. The method of claim 1 wherein said nucleic acid is single or double stranded RNA.

9. The method of claim 1 wherein said partitioning is by chromatography.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc